Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$689M |
| 2 |
NVIDIA
NVDA
|
+$475M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
+$350M |
| 4 |
Microsoft
MSFT
|
+$347M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$262M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$185M |
| 2 |
Meta Platforms (Facebook)
META
|
+$131M |
| 3 |
Arm
ARM
|
+$91.4M |
| 4 |
CRH
CRH
|
+$78.5M |
| 5 |
Unity
U
|
+$69.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.11% |
| 2 | Industrials | 9.48% |
| 3 | Financials | 7.56% |
| 4 | Consumer Discretionary | 5.65% |
| 5 | Healthcare | 4.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DHC
2276
Diversified Healthcare Trust
DHC
$1.94B
| $119K | ﹤0.01% |
+12,768
| New | +$105K |
|
2277
Lexicon Pharmaceuticals
LXRX
$1.02B
| $119K | ﹤0.01% |
49,435
-25,675
| -34% | -$50K |
|
2278
Newell Brands
NWL
$2.59B
| $118K | ﹤0.01% |
+19,172
| New | +$81.1K |
|
|
AUNA
2279
Auna
AUNA
$390M
| $118K | ﹤0.01% |
+22,944
| New | +$116K |
|
2280
DMC Global
BOOM
$144M
| $117K | ﹤0.01% |
+20,078
| New | +$131K |
|
2281
Conduent
CNDT
$250M
| $116K | ﹤0.01% |
79,396
+4,701
| +6% | +$7.3K |
|
2282
FS KKR Capital
FSK
$3.29B
| $114K | ﹤0.01% |
10,884
-89,936
| -89% | -$967K |
|
2283
Bloomin' Brands
BLMN
$996M
| $114K | ﹤0.01% |
12,489
-15,478
| -55% | -$113K |
|
|
NHICW
2284
NewHold Investment Corp III Warrants
NHICW
$16.7M
| $114K | ﹤0.01% |
55,000
-25,000
| -31% | -$36.4K |
|
2285
Janus International
JBI
$697M
| $113K | ﹤0.01% |
20,410
-58
| -0.3% | -$304 |
|
2286
Beyond Meat
BYND
$254M
| $111K | ﹤0.01% |
+4,947
| New | +$115K |
|
|
SLMT
2287
Brera Holdings
SLMT
$47.1M
| $111K | ﹤0.01% |
21,922
-61,144
| -74% | -$398K |
|
2288
Evolent Health
EVH
$536M
| $111K | ﹤0.01% |
20,447
-42,896
| -68% | -$164K |
|
|
FABC
2289
Fabric.AI Inc
FABC
$19.8M
| $111K | ﹤0.01% |
+30,000
| New | +$108K |
|
2290
Allogene Therapeutics
ALLO
$722M
| $110K | ﹤0.01% |
+53,079
| New | +$117K |
|
2291
eGain
EGAN
$200M
| $110K | ﹤0.01% |
17,407
+1,193
| +7% | +$8.75K |
|
2292
Treace Medical Concepts
TMCI
$282M
| $109K | ﹤0.01% |
+27,277
| New | +$75K |
|
2293
Perion Network
PERI
$386M
| $108K | ﹤0.01% |
+11,149
| New | +$106K |
|
2294
Array Technologies
ARRY
$722M
| $108K | ﹤0.01% |
+14,562
| New | +$116K |
|
2295
Altimmune
ALT
$605M
| $107K | ﹤0.01% |
+35,077
| New | +$105K |
|
2296
Byrna Technologies
BYRN
$84.1M
| $107K | ﹤0.01% |
15,881
+1,287
| +9% | +$7.91K |
|
2297
Ocular Therapeutix
OCUL
$2.43B
| $105K | ﹤0.01% |
+10,711
| New | +$97.1K |
|
|
OBE
2298
Obsidian Energy
OBE
$797M
| $105K | ﹤0.01% |
12,888
-26,984
| -68% | -$303K |
|
2299
Entera Bio
ENTX
$559M
| $104K | ﹤0.01% |
58,871
+3,648
| +7% | +$4.56K |
|
|
CEPS
2300
Cantor Equity Partners VI
CEPS
| $104K | ﹤0.01% |
10,000
| – | – |
|
Similar funds
Steve Schonfeld's Q2 2026 Portfolio in Review
As of Q2 2026, Steve Schonfeld held 3,207 positions worth $27.9B, up 96% from $14.2B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Steve Schonfeld deployed $11.3B of net new capital in Q2 2026, opening 1,059 new positions and adding to 750 existing holdings. Its largest new stake was iShares MSCI Brazil ETF: 9,366,387 shares worth $323M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $185M trimmed.
- Steve Schonfeld's largest Q2 2026 buy was iShares MSCI Brazil ETF: 9,366,387 shares worth $323M.
- Steve Schonfeld added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $689M increase.
- Steve Schonfeld's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $185M.
- Steve Schonfeld fully exited Marvell Technology in Q2 2026, selling an estimated $60.3M.
- Steve Schonfeld's ten largest holdings make up 29% of its $27.9B portfolio in Q2 2026.
- Steve Schonfeld opened 1,059 new positions and closed 651 in Q2 2026.
- Steve Schonfeld's portfolio value rose 96% quarter-over-quarter to $27.9B.
Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.